Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Date Issued
2023
Author(s)
Wu, Huan-Yi
Chang, Peng-Hao
Tsai, Chin-Shiang
Chen, Kuan-Yu
Lin, I-Fan
Hsih, Wen-Hsin
Tsai, Wan-Lin
Chen, Jiun-An
Yang, Te-Liang
Lee, Chun-Yuan
Ho, Tzong-Shiann
Wang, Hsiao-Wei
Huang, Shiang-Fen
Wu, Alice Ying-Jung
Chen, Hung-Jui
Chen, Yi-Ching
Chen, Wan-Chen
Tseng, Chien-Hao
Lin, Pei-Chin
Yang, Ching-Hsiang
Hong, Pi-Lien
Lee, Susan Shin-Jung
Chen, Yao-Shen
Liu, Yung-Ching
Wang, Fu-Der
Chan, Yu-Jiun
Chang, Feng-Yee
Chang, Hou-Tai
Chen, Yen-Hsu
Cheng, Ming-Fang
Chi, Hsin
Chiu, Cheng-Hsun
Ho, Mao-Wang
Huang, Chien-Hsien
Hwang, Kao-Pin
Kao, Kuo-Chin
Ko, Wen-Chien
Kuo, Chien-Feng
Lai, Chung-Hsu
Lee, Nan-Yao
Lee, Shin-Jung
Lin, Hsi-Hsun
Lin, Yi-Tsung
Liu, Ching-Chuan
Liu, Po-Yu
Lu, Po-Liang
Tang, Hung-Jen
Tsai, Hung-Chin
Wu, Ting-Shu
Yang, Chia-Jui
Abstract
Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections and more than 6.6 million deaths up to Nov 25, 2022. COVID-19 carries a high mortality rate in severe cases. Co-infections and secondary infections with other micro-organisms, such as bacterial and fungus, further increases the mortality and complicates the diagnosis and management of COVID-19. The current guideline provides guidance to physicians for the management and treatment of patients with COVID-19 associated bacterial and fungal infections, including COVID-19 associated bacterial infections (CABI), pulmonary aspergillosis (CAPA), candidiasis (CAC) and mucormycosis (CAM). Recommendations were drafted by the 7th Guidelines Recommendations for Evidence-based Antimicrobial agents use Taiwan (GREAT) working group after review of the current evidence, using the grading of recommendations assessment, development, and evaluation (GRADE) methodology. A nationwide expert panel reviewed the recommendations in March 2022, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes the epidemiology, diagnostic methods and treatment recommendations for COVID-19 associated infections. The aim of this guideline is to provide guidance to physicians who are involved in the medical care for patients with COVID-19 during the ongoing COVID-19 pandemic.
Subjects
CABI; CAC; CAM; CAPA; COVID-19; COVID-19 associated infections; Candidiasis; Mucormycosis; Pulmonary aspergillosis
SDGs
Type
review